The association between chronic spontaneous urticaria and HLA class I and class II antigen

The association between chronic spontaneous urticaria and HLA class I and class II antigen

Background/aim: Chronic spontaneous urticaria (CSU) is a chronic disease with an unknown etiology. In human leukocyte antigen (HLA) system, the association of class I and class II antigens with autoimmune diseases has been identified and HLA antigens that have a tendency to or can prevent chronic urticaria have been studied. The aim of this study is to investigate the association between chronic spontaneous urticaria and HLA class I and class II antigens. Materials and methods: A total of 80 subjects, 40 patients with CSU and 40 healthy individuals were enrolled in the study. DNA sample isolation from blood was primarily done by the real-time polymerase chain reaction (RT-PCR) technique for the first time. Using HLA SSP Typing Kit (ROSE Cat. No: 800118) PCR technique, HLA-A, B, C, DRB and DQB alleles from DNA samples were analyzed. Results: The mean age was 36.80 ± 9.48 years and the duration of the disease was 4.26 ± 5.18 years. Among the HLA class I and class II antigens, HLA-A was detected significantly more often in the control group (P = 0.039). HLA-DRB1 was more often detected in the CSU group but no statistical difference (P > 0.05). Conclusion: It can be considered that HLA-DRB1 may have a tendency to CSU, while HLA-A might prevent the disease.

___

  • 1. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D et al. The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2017 revision and update. Allergy 2018; 73 (7): 1393-1414. doi: 10.1111/all.13397
  • 2. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK et al. EAACI/GA2 LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64 (10): 1417-1426. doi: 10.1111/j.1398-9995.2009.02179.x
  • 3. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clinical Experimental Allergy 2009; 39 (6): 777-787. doi: 10.1111/j.1365-2222.2009.03256.x
  • 4. Saini SS. Chronic spontaneous urticaria: etiology and pathogenesis. Immunology Allergy Clinics of North America 2014; 34 (1): 33-52. doi: 10.1016/j.iac.2013.09.012
  • 5. Zuberbier T, Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy. Acta Dermato-Venereologıca 2007; 87 (3): 196-205. doi: 10.2340/00015555-0240
  • 6. Philpott H, Kette F, Hissaria P, Gillis D, Smith W. Chronic urticaria: the autoimmune paradigm. Internal Medicine Journal 2008; 38 (11): 852-857. doi: 10.1111/j.1445-5994.2008.01673.x
  • 7. Tsai S, Santamaria P. MHC class II polymorphisms, autoreactive T-cells, and Autoimmunity. Frontiers of Immunology 2013; 4: 321. doi: 10.3389/fimmu.2013.00321
  • 8. Bettencourt A, Carvalho C, Leal B, Brás S, Lopes D et al.The Protective Role of HLA-DRB113 in Autoimmune Diseases. Journal of Immunology Research 2015; 948723. doi: 10.1155/2015/948723
  • 9. O’Donnell BF, O’Neill CM, Francis DM, Niimi N, Barr RM et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. British Journal of Dermatology1999; 140 (5): 853-858.doi: 10.1046/j.1365-2133.1999.02815.x
  • 10. Öztas P, Önder M, Gönen S, Öztaş MO, Söylemezoğlu O. Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Medical Journal 2004; 45 (3): 392-395. doi: 10.3349/ ymj.2004.45.3.392
  • 11. Chen J, Tan Z, Li J, Xiong P. Association of HLA-DRB1, DQB1 alleles with chronic urticaria. Journal of Huazhong University Science and Technology [Med Sci] 2005; 25: 354-356. doi: 10.1007/BF02828166
  • 12. Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clinical and Experimental Dermatology 2006; 31 (3): 424-429. doi: 10.1111/j.1365-2230.2005.02039.x
  • 13. Çoban M, Erdem T, Özdemir Ş, Pirim İ, Atasoy M et al. HLA class I and class II genotyping in patients with chronic urticaria. International Archives of Allergy and Immunology 2008; 147 (2): 135-139. doi: 10.1159/000135700
  • 14. Bozek A, Krajewska J, Filipowska B, Polanska J, Rachowska R et al. HLA status in patients with chronic spontaneous urticaria. International Archives of Allergy and Immunology 2010; 153 (4): 419-423. doi: 10.1159/000316354
  • 15. Calamita Z, Pelá AB, Gamberini M, Baleotti Júnior W, Almeida Filho OM et al. HLA among Brazilian patients with spontaneous chronic urticaria and positive autologous serum skin test. Anais Brasileiros de Dermatologia 2012; 87 (4): 578- 583. doi: 10.1590/S0365-05962012000400010
  • 16. Calamita Z, Bronhara Pelá Calamita A. Chronic spontaneous urticaria: epidemiological characteristics focusing on the histocompatibility profile and presence of antibodies. Inflammation Allergy-Drug Targets 2013; 12 (1): 8-11. doi: 10.2174/1871528111312010002
  • 17. Gaig P, Olona M, Muñoz Lejarazu D, Caballero MT, Domínguez FJ et al. Epidemiology of urticaria in Spain. Journal of Investigational Allergology and Clinical Immunology 2004; 14 (3): 214-220.
  • 18. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types ofurticaria. Alergológica 2005. Journal of Investigational Allergology and Clinical Immunology 2009; 19 (2): 21-26.
  • 19. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. British Journal of Dermatology 1981; 104 (4): 369- 381. doi: 10.1111/j.1365-2133.1981.tb15306.x
  • 20. Greaves M. Chronic urticaria. The Journal of Allergy and Clinical Immunology 2000; 105 (4): 664-672. doi: 10.1067/ mai.2000.105706
  • 21. Nebiolo F, Bommarito L, Bugiani M, Heffler E, Carosso A et al. Effect of arterial hypertension on chronic urticaria duration. Annals of Allergy, Asthma & Immunology 2009; 103: 407-410. doi:10.1016/S1081-1206(10)60360-2
  • 22. Haas N, Iwen W, Grabbe J, Uchanska-Ziegler B, Czarnetzki BM. MHC class II antigen expression is increased in different forms of urticaria. International Archives of Allergy and Immunology 1996; 109 (2): 177-182. doi: 10.1159/000237217
  • 23. Calamita Z, Bronhara Pelá Calamita A. HLA in patients with chronic spontaneous urticaria who are positive for anti-thyroid antibodies. Journal of the European Academy of Dermatology and Venereology 2013; 27 (5): 661-662. doi: 10.1111/j.1468- 3083.2012.04573.x
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Radiological approaches to COVID-19 pneumonia

Recep SAVAŞ, Tuncay HAZIROLAN, Furkan UFUK

Coenzyme Q10, Zinc and MDA levels in verruca vulgaris

Fevziye Burcu ŞİRİN, Selma KORKMAZ, İjlal ERTURAN, Mehmet YILDIRIM, Halil İbrahim BÜYÜKBAYRAM

Antioxidant effects of dexmedetomidine against hydrogen peroxide-induced DNA damage in vitro by alkaline Comet assay

Ela KADIOĞLU, Esra EMERCE, Ayşe ÖZCAN, Çetin KAYMAK, Hülya BAŞAR, Mustafa S. KOTANOĞLU, Hülya BAŞAR

Presence of paroxysmal nocturnal hemoglobinuria in patients with idiopathic portal vein thrombosis: a single-center study

Senar EBİNÇ, Cengiz DEMİR, Ömer EKİNCİ

Characteristics of the initial patients hospitalized for COVID-19: a single-center report

Alpay MEDETALİBEYOĞLU, Gazi ÇAPAR, Tufan TÜKEK, Naci ŞENKAL, Murat KÖSE

Surface enhanced Raman spectroscopy as a novel tool for rapid quantification of heroin and metabolites in saliva

Mahmut Şerif YILDIRIM, Necdet SAĞLAM, Hasan İLHAN, Ramazan AKÇAN, Uğur TAMER, Burcu GÜVEN

Association between monocyte to high-density lipoprotein cholesterol ratio and bicuspid aortic valve degeneration

Telat KELEŞ, Hüseyin AYHAN, Bilge DURAN KARADUMAN, Engin BOZKURT

Alterations in follicular fluid BMP-15 RNA expression in women undergoing controlled ovarian hyperstimulation

Şükriye Derya DEVECİ

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat

Mustafa ÇELEBİER, İbrahim Celalettin HAZNEDAROĞLU

Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence

Emre TEKGÖZ, Sedat YILMAZ, Seda ÇOLAK, Muhammet ÇINAR